The shareprice has been controlled to a small trading range since it was brought down after our last trading halt ( which saw
immediate large sales at 20 cents to limit price reaction to ann ), concerning the second ocular drug program.
The price control has been ongoing ever since, for the entire month of August and into September now, preceeding funding and partnering
talks or at the initiation of the same.
Therefore, I would not only attribute today's volume for such practices in play.
It is common place and this is currently avoiding an appreciation of price prior to expected news early 4th Q.
all IMO
The shareprice has been controlled to a small trading range...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.035(2.75%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.22 | $162.1K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3818 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |